Fibroadenoma

Fibroadenoma is a benign tumor of the glandular tissue of the mammary gland, which is most often detected in women of reproductive age. This tumor consists of a combination of fibrous and glandular-epithelial tissue, which determines its characteristic structural features. Fibroadenomas are round or oval in shape, mobile and, as a rule, painless to the touch. These formations are often diagnosed by chance during a mammogram or ultrasound examination of the mammary gland, since they may not show any symptoms. A biopsy analysis helps to confirm the diagnosis, but in most cases, fibroadenomas do not require immediate treatment, unless there is an increase in the size of the tumor or changes in its structure.

History of the disease and interesting historical facts

Fibroadenoma was first described in medical literature over a century ago. In the 1930s, scientists began to classify these tumors, distinguishing them from other breast masses. It is important to note that fibroadenomas have been studied in various cultures, and in some cases, they have been viewed as “female tumors,” reflecting certain social and medical views. Medieval surgeons described fibroadenomas as “circles” or “lumps” that should be removed, but over time, the approach to diagnosing and treating this condition has changed, leading to more informed and safer management of this pathology.

Epidemiology

According to modern research, fibroadenoma is one of the most common breast diseases in women. According to statistics, its prevalence is about 10-15% of the total number of detected breast diseases. At the age of 15 to 35 years, fibroadenomas are more common in women, and after 35 years, their frequency gradually decreases. The above analysis shows that in recent decades, the number of fibroadenoma cases has increased, which may be due to lifestyle changes, environmental factors and changes in diet. It is important to consider that the frequency of fibroadenomas may vary in different regions and populations, which requires further research to identify all possible causes.

Genetic predisposition to this disease

Research shows that women with a family history of breast disease have an increased risk of developing fibroadenomas. Certain genes have been identified that are associated with this condition, including BRCA1 and BRCA2, although their specific association with fibroadenoma is not as clear as with breast cancer. Mutations in these genes can predispose to the development of various tumors. Epidemiological data confirm that a history of fibroadenomas in one of the first-degree relatives may increase the risk of their occurrence.

Risk factors for the development of this disease

There are various risk factors that contribute to the development of fibroadenomas, which include:

• Hormonal changes, especially during puberty and pregnancy.
• Use of oral contraceptives, which can accelerate the development of such tumors.
• Poor nutrition and low physical activity, which can affect estrogen levels in the body.
• Age and race: Fibroadenomas are more common in women of African descent.
• Stress factors and the environment are also considered as potential triggers of the disease.

Diagnosis of this disease

Diagnosis of fibroadenoma includes several stages:

• Main symptoms: most often these are painless nodular formations in the mammary gland, which can increase in size.
• Laboratory tests: including hormone tests, which can help understand the cause of tumors.
• Radiologic examinations: Mammography and ultrasound are important tools for detecting and evaluating fibroadenomas.
• Other types of diagnostics: in some cases, magnetic resonance imaging may be required for a more detailed examination.
• Differential diagnosis: it is necessary to exclude other pathologies of the mammary gland, such as fibrocystic mastopathy or breast cancer, which often requires a biopsy.

Treatment

Treatment of fibroadenoma may vary depending on its size and dynamics:

• General treatment: not prescribed for small fibroadenomas, only regular monitoring is required.
• Pharmacological treatment: In particular, hormone therapy may be recommended to balance estrogen levels.
• Surgical treatment: removal of fibroadenoma is recommended in cases of its enlargement, changes in structure, or if there is a suspicion of malignancy.
• Other treatments include observational methods and, in rare cases, laser therapy, which is being studied for its effectiveness.

List of medications used to treat this disease

At the moment, there are no specific medications in medical practice for the treatment of fibroadenoma. However, the following are used:

• Hormonal drugs (eg, combined oral contraceptives to stabilize hormone levels).
• Medicines to reduce inflammatory processes if they accompany fibroadenomas.
• Pharmacological agents aimed at comprehensive management of the patient's condition.

Disease monitoring

Monitoring of the patient's condition with fibroadenoma includes regular examinations at intervals of 6 to 12 months. The prognosis is favorable in most cases, since fibroadenomas rarely develop into malignant tumors. Complications usually occur only in the absence of control and an increase in the size of the tumor, which may require more radical intervention.

Age-related features of the disease

Fibroadenomas are usually diagnosed in women between the ages of 15 and 35. However, the likelihood of their occurrence decreases with age. Fibroadenomas may be less common in older women, but their diagnosis may be difficult due to other changes in the breast that are typical for this age.

Questions and Answers

• What is fibroadenoma? Fibroadenoma is a benign tumor of the mammary gland, consisting of glandular and fibrous tissue.
• What are the causes of fibroadenoma? The main factors may be hormonal changes, genetic predisposition and external factors such as the environment.
• How is fibroadenoma diagnosed? Diagnosis includes physical examination, ultrasound, mammography and, if necessary, biopsy.
• Should fibroadenoma be removed? Removal is recommended if the tumor grows or changes in its nature; otherwise, observation is sufficient.
• What is the prognosis for fibroadenoma? The prognosis is favorable in most cases, since fibroadenomas rarely cause complications and rarely transform into malignant tumors.

Advice from Dr. Oleg Korzhikov

It is important to remember that fibroadenoma is a disease that requires regular monitoring. Many women wonder whether it is necessary to have surgery if fibroadenoma does not bother them. The answer is simple: in most cases, the growth dynamics of the formation is indicative. Monitoring every 6-12 months is necessary if the formation does not cause concern. It is also worth paying attention to changes in the breast and, if new symptoms appear, be sure to consult a doctor. If a tumor is detected, it is important to remain calm and focus on observation and consultations with doctors.